After trading in tight range for
most part of the session, the Indian equity benchmarks have snapped the day
with about half a percent gains. Sentiments remained upbeat with Finance
Minister Arun Jaitley terming the GST bill revolutionary and hoping all the
political parties would pass the related bills through consensus in the current
session of Parliament. Allaying apprehension of spike in prices of goods and
commodities after the roll out of the GST, Jaitley said the tax rates will be
kept at the current levels so as not to have any inflationary impact. Further,
the rupee strengthened to a 17-month high of 64.95 against the dollar, which
also helped improve the risk appetite. Adding optimism among investors, Minister
of State for Planning Rao Inderjit Singh said that long-term strategic plans
are being prepared for overall development of the country and consultations
with states and other stakeholders have been completed with respect to these
proposed initiatives. Some support also came with the report that foreign
portfolio investors (FPIs) bought shares worth a net Rs 6415.38 crore on March
28, 2017. However, gains remained capped with the report that Reserve Bank of
India is likely to keep policy rates on hold this year but there are risks
tilted towards a hike in 2018. According to the report, inflation is likely to
remain within the RBI's target range of 2-6%, but India is still some time away
from bringing inflation to its 4% target sustainably. Meanwhile, shares of
major automobile majors took a hit as investors turned cautious of the Supreme
Court's verdict on BS-III vehicles. A bench of justices Madan B Lokur and
Deepak Gupta said that health of millions of citizens was more important that
commercial interests of manufacturers and directed the government not allow
registration of polluting BS-III vehicles after March 31. Finally, the BSE
Sensex surged 121.91 points or 0.41% to 29531.43, while the CNX Nifty was up by
43 points or 0.47% to 9,143.80.
The US markets closed mostly
higher on Wednesday, though the Dow industrials finished lower, as stock
investors digested hawkish comments from Federal Reserve speakers and a drop in
US gasoline inventories bolstered the energy sector. Investors are focusing too
much on the drama of President Donald Trump and Congress to appreciate the
economic underpinnings of the market. On the economy front, contract signings
for home sales boomed in February to the second-highest level in a decade.
Pending home sales rose 5.5% in February after falling 2.8% in January. That's
the highest level in close to a year. The National Association of Realtors
forecasts a 2.3% rise in existing-home sales and a 4% rise in median home
prices for 2017, after a 3.8% rise in existing sales and a 5.1% price rise in
2016. Meanwhile, Boston Fed President Eric Rosengren said that the US Federal
Reserve should raise interest rates three more times this year due to the
strength of the economy. The Nasdaq was up 22.41 points or 0.38 percent to
5,897.55, S&P 500 gained 2.56 points or 0.11 percent to 2,361.13, while the
Dow Jones Industrial Average lost 42.18 points or 0.20 percent to 20,659.32.
Crude oil futures surged on
Wednesday, extending their gains for the second consecutive session, after the
latest Energy Information Administration (EIA) report showed a smaller than
expected rise in US crude stockpiles while output disruptions in Libya
continued to lift sentiment. For the week ending March 22, The EIA said that
crude oil inventories rose by 0.867 million barrels compared to estimates of an
increase of 1.357 million barrels. At the same time, gasoline inventories
continued to fall, dropping another 3.7 million barrels in a sign of impending
demand for crude oil in the coming weeks. Benchmark crude oil futures for May
delivery moved higher by $1.14 or 2.4% to $49.51 on the New York Mercantile
Exchange. In London, Brent crude for May delivery ended higher by $0.98 at $52.40
on the ICE.
Indian rupee appreciated against
dollar to hit a fresh 17-month high and breached 65-mark on Wednesday on
increased liquidation of the American currency by exporters and banks. This is
the third consecutive session when the rupee traded higher against dollar.
Domestic currency got some support with the Care ratings' report that it
expects GDP growth to accelerate to 8 percent next financial year as against
7.1 percent in this year as per the latest CSO estimate and added that the
monsoon will be the only domestic risk factor which may scupper this. Besides,
gains in the domestic equity market and continued foreign inflows made the
going easy for the rupee. However, the dollar's recovery against some
currencies overseas restricted the rupee up move. On the global front, sterling
battled back from a one-week low and regained its composure amid the drama of
Britain formally triggering its exit process from the European Union. Finally,
the rupee ended at 64.91, 13 paise stronger from its previous close of 65.04 on
Monday.
The FIIs as per Wednesday's data
were net buyers in equity and debt segments both. In equity segment, the gross
buying was of Rs 21367.12 crore against gross selling of Rs 14015.17 crore,
while in the debt segment, the gross purchase was of Rs 8211.75 crore with
gross sales of Rs 1251.56 crore.
The US markets once again showed
a lackluster trade and made a mixed closing in last session. Traders seemed
reluctant to make any significant moves amid continued uncertainty about
President Donald Trump's policy agenda following the failure of the Republican
health care bill. The Asian markets have made a weak start and some of the
indices are down by about half a percent, the Japanese market too was lower
despite the yen weakening and crude holding on to last day's surge. The Indian
markets extended gains in last session, with major benchmarks adding about
another half a percent and the rupee hitting a 17-month high to breach the
65-mark against the dollar on strong capital inflows as the much-awaited GST
Bill discussion started in the Lok Sabha. Today, the start of the F&O
series expiry session is likely to be a bit soft to flat tailing weak global
cues. However, market may recover soon as the Lok Sabha passed all four GST
Bills to make India's new tax regime effective from July 1. The four GST Bills
were passed after an eight-hour marathon debate in the Lower House. Markets may
see volatility towards the series expiry with traders rolling over their
positions to the next series. Meanwhile, chief economic adviser Arvind
Subramanian has said that the twin balance sheet problem - over-leveraged
companies and bad-loan-encumbered banks - is perhaps India's top macroeconomic
challenge at the moment and how much of haircut the banks will have to take is
at the core of the problem. The auto stocks will continue to reel under
pressure after the Supreme Court banned sale and registration of BS-III
vehicles from April 1. Refusing to extend the March 31 deadline, the apex court
observed that the health of the citizen is more important than the commercial
interests of the automobile industry.
Support and Resistance: NSE (Nifty) and BSE
(Sensex)
Index
|
Previous close
|
Support
|
Resistance
|
NSE Nifty
|
9143.80
|
9117.55
|
9161.60
|
BSE Sensex
|
29531.43
|
29462.44
|
29577.41
|
Nifty Top volumes
Stock
|
Volume
(in Lacs)
|
Previous close (Rs)
|
Support
(Rs)
|
Resistance (Rs)
|
SBI
|
310.08
|
288.45
|
284.43
|
291.18
|
IDEA
|
255.17
|
88.90
|
88.27
|
89.62
|
Bank of Baroda
|
209.52
|
173.50
|
172.17
|
175.52
|
ICICI Bank
|
171.92
|
282.20
|
278.30
|
284.45
|
Bharti Infratel
|
136.86
|
336.85
|
324.35
|
345.10
|
TCS has expanded long-standing partnership with Siemens to deliver a comprehensive set of plant solutions for enabling the connected Digital Enterprise.
Axis Bank has received an approval for allotment of 3 year Senior Floating Rate Notes aggregating to $10 million, under the MTN Programme through its Dubai International Financial Centre branch.
IndusInd Bank has extended its agreement with Lohia Auto Industries for financing their electric three wheelers under the e-rickshaw category.
Lupin has launched Abacavir and Lamivudine tablets, 600 mg/300 mg having received an approval from the USFDA earlier.